Cargando…

Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumour

Non-functional pancreatic neuroendocrine tumours (NETs) can present with advanced local or distant (metastatic) disease limiting the possibility of surgical cure. Several treatment options have been used in experimental neoadjuvant settings to improve the outcomes in such cases. Peptide receptor rad...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Silva, Tiago Nunes, van Velthuysen, M L F, van Eijck, Casper H J, Teunissen, Jaap J, Hofland, J, de Herder, Wouter W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2018
Materias:	Unusual Effects of Medical Treatment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900461/ https://www.ncbi.nlm.nih.gov/pubmed/29675259 http://dx.doi.org/10.1530/EDM-18-0015

Ejemplares similares

Prolonged life-threatening hypoglycaemia following dose escalation of octreotide LAR in a patient with malignant polysecreting pancreatic neuroendocrine tumour
por: Abell, Sally K, et al.
Publicado: (2015)

Treatment with somatostatin analogues and PRRT in metastatic middle ear adenoma with neuroendocrine features
por: Lima Ferreira, Joana, et al.
Publicado: (2021)

Evolution of the Mesenteric Mass in Small Intestinal Neuroendocrine Tumours
por: Blažević, Anela, et al.
Publicado: (2021)

Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)
por: Sowa-Staszczak, Anna, et al.
Publicado: (2011)

Fluticasone furoate induced iatrogenic Cushing syndrome in a pediatric patient receiving anti-retroviral therapy
por: van den Berg, S A A, et al.
Publicado: (2017)

Salvage peptide receptor radionuclide therapy with [(177)Lu-DOTA,Tyr(3)]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours
por: van der Zwan, W. A., et al.
Publicado: (2018)

Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors
por: Opalińska, Marta, et al.
Publicado: (2021)

Severe hypercalcemia and hypernatremia in a patient treated with canagliflozin
por: Kaur, Arshpreet, et al.
Publicado: (2015)

A novel melanoma therapy stirs up a storm: ipilimumab-induced thyrotoxicosis
por: Yu, Christine, et al.
Publicado: (2015)

Live birth using autologous sperm cryopreserved for 26 years
por: Sleiman, Sue, et al.
Publicado: (2023)

Estradiol: micrograms or milligrams
por: Kirk, Jeremy M W, et al.
Publicado: (2016)

Accidental exposure to glimepiride from adulterated medication resulting in severe hypoglycaemia
por: Hayes, Annabelle G, et al.
Publicado: (2022)

Central venous catheter-associated thrombosis in children with congenital hyperinsulinism
por: Yau, Daphne, et al.
Publicado: (2019)

Vandetanib induces a marked anti-tumor effect and amelioration of ectopic Cushing’s syndrome in a medullary thyroid carcinoma patient
por: Bseiso, Hashem, et al.
Publicado: (2016)

An unusual case of shortness of breath
por: Wan Muhammad Hatta, S F, et al.
Publicado: (2018)

Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump
por: Boronat, Mauro, et al.
Publicado: (2015)

Mitotane in the treatment of childhood adrenocortical carcinoma: a potent endocrine disruptor
por: Oddie, Philip D, et al.
Publicado: (2018)

Progestin-related breast volume changes in a woman with complete androgen insensitivity syndrome (CAIS)
por: Dijkman, Benthe A M, et al.
Publicado: (2023)

Methimazole-induced myositis: a case report and review of the literature
por: Bou Khalil, R, et al.
Publicado: (2013)

Induction therapy with (177)Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients
por: Minczeles, Noémie S., et al.
Publicado: (2022)

Reversible alterations in cardiac morphology and functions in a patient with Cushing's syndrome
por: Iwasaki, Hiroaki
Publicado: (2014)

Painful fat necrosis resulting from insulin injections
por: Hanson, P, et al.
Publicado: (2014)

Intermittent everolimus administration for malignant insulinoma
por: Baratelli, Chiara, et al.
Publicado: (2014)

One year remission of type 1 diabetes mellitus in a patient treated with sitagliptin
por: Lima-Martínez, Marcos M, et al.
Publicado: (2014)

Too little or too much corticosteroid? Coexisting adrenal insufficiency and Cushing's syndrome from chronic, intermittent use of intranasal betamethasone
por: Dow, Adrienne, et al.
Publicado: (2013)

GH replacement causing acute hyperglycaemia and ketonuria in a type 1 diabetic patient
por: Cavlan, Dominic, et al.
Publicado: (2013)

Adrenal insufficiency in acute oral opiate therapy
por: Policola, Caterina, et al.
Publicado: (2014)

Adrenal insufficiency in a woman secondary to standard-dose inhaled fluticasone propionate therapy
por: Hay, Casey M, et al.
Publicado: (2014)

Opioid-induced secondary adrenal insufficiency presenting as hypercalcaemia
por: Lee, Angela S, et al.
Publicado: (2015)

Onset of Graves' disease during long-term immunosuppressive therapy in a patient with membranous nephropathy
por: Iwasaki, Hiroaki
Publicado: (2015)

A case of thyroid storm complicated by acute hepatitis due to propylthiouracil treatment
por: Tufton, Nicola, et al.
Publicado: (2015)

A macroprolactinoma becoming resistant to cabergoline and developing atypical pathology
por: Sbardella, Emilia, et al.
Publicado: (2016)

Hyponatraemia secondary to nivolumab-induced primary adrenal failure
por: Trainer, Harris, et al.
Publicado: (2016)

Active postoperative acromegaly: sustained remission after discontinuation of somatostatin analogues
por: Alvarez-Escola, Cristina, et al.
Publicado: (2016)

Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3
por: Pinheiro, Marcelo Maia, et al.
Publicado: (2016)

New-onset insulin-dependent diabetes due to nivolumab
por: Zaied, Ali A, et al.
Publicado: (2018)

Low carbohydrate diet and improved glycaemic control in a patient with type one diabetes
por: Eiswirth, Mirjam, et al.
Publicado: (2018)

Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditis
por: Tzoulis, Ploutarchos, et al.
Publicado: (2018)

A case with relapsed transient neonatal diabetes mellitus treated with sulfonylurea, ending chronic insulin requirement
por: Ando, Akihiko, et al.
Publicado: (2018)

A surprising treatment response in a patient with rare isolated growth hormone deficiency, type IB
por: Amar, Jordan Yardain, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qrjgjjshcl1ejj6j9ch4b178va